Get started
Author

A. V. Korobkin

Observed names: A V Korobkin, Aleksandr V. Korobkin, Aleksandr Vladimirovich Korobkin, Коробкин Александр Владимирович
Observed institution: Regional Clinical Hospital No 4
ORCID: 0000-0003-4922-3742
Observed ORCID: 0000-0003-4922-3742
OpenAlex ID: A5066477034
The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
2021 · Aleksandr D. Kulagin, Bulat A. Bakirov, et al. · Terapevticheskii arkhiv · 3
PDF
The role of oxidative stress in bone tissue in the pathogenesis of osteopenia in patients with chronic lymphocytic leukemia
2024 · M. V. Osikov, E. A. Korobkin, et al. · Гематология и трансфузиология
PDF
Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
2024 · M. V. Solovev, M. V. Solovevа, et al. · Oncohematology
PDF
Incidence and mortality rates of tumors of the hematopoietic and lymphoid tissues in a cohort of workers chronically exposed to ionizing radiation
2023 · T. V. Azizova, E. V. Bragin, et al. · Гематология и трансфузиология
PDF
Rekomendatsii po obsledovaniyu i lecheniyu bol'nykh V-kletochnym khronicheskim limfoleykozom
2008 · Stanislav Semenovich Bessmel'tsev, Tat'yana Evgen'evna Byalik, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
[Erythropoiesis inhibitor in the plasma of patients with hemopoietic dysplasias].
1989 · V I Gudim, A V Korobkin, et al. · PubMed
Works count: 7
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type